Mirador Therapeutics, Inc.
Clinical trials sponsored by Mirador Therapeutics, Inc., explained in plain language.
-
New hope for IBD sufferers: experimental drugs enter Mid-Stage trial
Disease control Recruiting nowThis study tests several new investigational drugs in 140 adults with moderate-to-severe Crohn's disease or ulcerative colitis. The main goals are to check safety and see if the drugs can improve symptoms and reduce gut inflammation seen on camera exams. Participants must have a …
Phase: PHASE2 • Sponsor: Mirador Therapeutics, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
New drug MT-201 tested in healthy people for first time
Knowledge-focused Recruiting nowThis early-stage study tests the safety of a new drug called MT-201 in 72 healthy adults aged 19 to 55. Participants receive either the drug or a placebo to check for side effects and how the body processes the drug. The goal is to gather initial safety data, not to treat any dis…
Phase: PHASE1 • Sponsor: Mirador Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC